Normally both drugs offer a route through which one can lose weight, but they differ in their abilities, side effects, and costs
Although these agents improve glucose levels in patients with type 2 diabetes, their weightlowering effects may be as or more clinically meaningful for patients with obesity
They can advise you on whether theyre safe to use while taking Januvia
Foundational GLP-1 Physiology Review (PubMed, 2007) GLP-1 as Incretin, Enterogastrone, and Appetite Regulator Establishing the Full Physiological Profile A comprehensive review of GLP-1 physiology published on PubMed confirmed that GLP-1 is a 30-amino acid peptide hormone produced in intestinal L-cells by differential processing of proglucagon, released in response to meal intake
For patients who already carry subclinical gut inflammation, the added pharmacological load on the intestinal lining can translate into meaningful discomfort and compromised nutrient absorption during a period when dietary intake is already significantly reduced